Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Short-term Investments (2022 - 2026)

Alx Oncology Holdings' Short-term Investments history spans 2 years, with the latest figure at $160.3 million for Q4 2023.

  • On a quarterly basis, Short-term Investments fell 26.25% to $160.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was $160.3 million, a 26.25% decrease, with the full-year FY2023 number at $160.3 million, down 26.25% from a year prior.
  • Short-term Investments hit $160.3 million in Q4 2023 for Alx Oncology Holdings, down from $170.4 million in the prior quarter.
  • Over the last five years, Short-term Investments for ALXO hit a ceiling of $247.0 million in Q2 2022 and a floor of $157.5 million in Q1 2022.